Why the study?
Primary Gastrointestinal Angiosarcoma is a rare malignant tumor, prompting a review to elucidate its biological behavior and optimal therapeutic approach.
Design
Systematic review
Authors
Loading...
Poor prognosis in small-intestine and multifocal PGAS warrants clinical caution; extends sparse case data and leaves optimal management open.
Primary Gastrointestinal Angiosarcoma is a rare and aggressive malignancy with poor survival outcomes, particularly for multifocal and small intestine presentations.
Schizas et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: